AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75D30120C08055BAYLOR RESEARCH INSTITUTE
Overview
Award facts
- Net obligations
- $1.46M
- $1,464,865of $1.50M potential value
- Outlays (paid to date)
- $1.02M
- $1.02M paid of $1.46M obligated$1,017,120
- Period of performance
- May 4, 2020 to Dec 31, 2021
- Ended
- Modifications
- 3
- Latest action Aug 25, 2022
- Contract type
- Definitive contract
- PIID 75D30120C08055
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
BAA 2020 BAYLOR SCOTT&WHITE
Dates and value
- Award date
- Signed on May 4, 2020
- Potential end of performance
- Dec 30, 2021
- Current value
- $1,500,000Base and exercised options
- Potential value (if all options are exercised)
- $1,500,000
Obligations by fiscal year of action
- FY2022: -$35,135 (de-obligation)
- FY2020: $1,500,000
Total across 2 fiscal years: $1,464,865
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 25, 2022. View on USAspending · Recipient on SAM.gov
Recipient
LocationDALLAS, TX
UEIJ1G9CV11VCN7
CAGE code1SSZ9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt
Parent companyBAYLOR RESEARCH INSTITUTE
Business types and certifications
Nonprofit organizationTax-exempt corporation
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Centers For Disease Control And Prevention
- CDC OFFICE OF ACQUISITION SERVICES
- Funded by
- Department of Health and Human Services
- Centers For Disease Control And Prevention
- CDC OFFICE OF ACQUISITION SERVICES
- Funded from
- Cdc wide activities and program support (0943); Immunization and respiratory diseases (0951)Program activities075-0943, 075-0951Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Dallas, Texas 75201-3024
- Congressional district (place of performance)
- TX-30As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Basic researchBR
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- 75D30120Q71717(as reported)
- Solicitation date
- Nov 22, 2019
Contract details
- Subcontracting plan
- Individual subcontract planF
- Cost Accounting Standards clause
- No - CAS waiver approvedN
- Certified cost or pricing data
- Yes
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Transaction history
Modification history
- Base award
- May 4, 2020Base obligation at award: $1,500,000
- Latest action
- Aug 25, 2022 — Supplemental agreement (within scope)Modification P00003; obligation change -$35,135
- Latest substantive action
- Aug 25, 2022 — Supplemental agreement (within scope)Modification P00003; obligation change -$35,135
- Actions by type
- Base award1
- Supplemental agreement (within scope)2
- Other administrative action1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- National interest action
- COVID-19 2020P20C
- Contingency, humanitarian or peacekeeping operation
- Presidential issued emergency declaration, or a major disaster declarationC
Place and origin
- Domestic or foreign entity
- Other U.S. entity (e.g. government)B
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7523
- Contracting office code
- 75D301
- Transactions recorded under this award key
- 4
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7523
- Funding office code
- 75D301
- Treasury accounts
- 075-2020/2020-0951-000
- 075-2020/2022-0943-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- L: Emergency P.L. 116-123
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- COVID-19 supplemental obligations
- $1,017,120
- COVID-19 supplemental outlays
- $1,017,120